| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/03/2009 | EP2065398A1 Human monoclonal nicotine specific antibodies |
| 06/03/2009 | EP2065396A1 Interleukin-19 |
| 06/03/2009 | EP2065393A1 Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| 06/03/2009 | EP2065392A2 Fusion antigen uses as vaccine |
| 06/03/2009 | EP2065052A2 Anti-IgE vaccines |
| 06/03/2009 | EP2065050A1 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 06/03/2009 | EP2064341A2 Prostate cancer related gene styk1 |
| 06/03/2009 | EP2064245A1 Methods for blocking the interaction between nkp80 and its ligand aicl |
| 06/03/2009 | EP2064242A1 Engineered anti-il-23p19 antibodies |
| 06/03/2009 | EP2064239A2 Anti-activin a antibodies and uses thereof |
| 06/03/2009 | EP2064235A1 The death receptor cd95 controls neurogenesis of adult neural stem cells in vivo and in vitro |
| 06/03/2009 | EP2064231A1 Immunoreactive glycoprotein gp19 of ehrlichia canis |
| 06/03/2009 | EP2064230A2 Immunogens from uropathogenic escherichia coli |
| 06/03/2009 | EP2064224A2 Tissue culture system for production of hepatitis c virus |
| 06/03/2009 | EP2063912A2 Polyalkylene oxides having hindered ester-based biodegradable linkers |
| 06/03/2009 | EP2063911A2 Immunogenic compositions for gram positive bacteria |
| 06/03/2009 | EP2063897A2 Kinase inhibitors useful for the treatment of proliferative diseases |
| 06/03/2009 | EP2063881A2 A composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer |
| 06/03/2009 | EP1660135B1 Method of treating hepatocellular carcinoma |
| 06/03/2009 | EP1603938B1 Inclusion bodies as antigens for the oral vaccination of animals against csfv |
| 06/03/2009 | EP1362058B1 Comparative ligand mapping from mhc positive cells |
| 06/03/2009 | EP1131426B1 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 06/03/2009 | EP1111054B1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/03/2009 | EP1012283B1 Mage-3 peptides presented by hla class ii molecules |
| 06/03/2009 | CN101448524A Cerebral vasospasm inhibitor |
| 06/03/2009 | CN101448523A Storage of influenza vaccines without refrigeration |
| 06/03/2009 | CN101448522A Pharmaceutical composition containing the NMB0938 protein |
| 06/03/2009 | CN101448521A Mycoplasma hyopneumoniae vaccine |
| 06/03/2009 | CN101448520A Avian influenza viruses, vaccines, compositions, formulations, and methods |
| 06/03/2009 | CN101446590A Methods for the identification of polypeptide antigens |
| 06/03/2009 | CN101445802A Novel porcine circovirus virus, vaccines and diagnosis agent |
| 06/03/2009 | CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/03/2009 | CN101445463A Beta2-adrenergic receptor agonists |
| 06/03/2009 | CN101444624A Medicine for cancer therapy |
| 06/03/2009 | CN101444623A Vaccine adjuvant |
| 06/03/2009 | CN101444622A Schistosoma japonicum gene recombination living vaccine production technique taking porcine pseudorabies virus as vector and product |
| 06/03/2009 | CN101444539A Use of strains of the parapox ovis virus against organ fibrosis |
| 06/03/2009 | CN100494388C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/03/2009 | CN100493617C Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof |
| 06/03/2009 | CN100493616C Polyepitope and composite polyepitope DNA vaccine of HIV |
| 06/03/2009 | CN100493607C Mixed heat shock protein/peptide sarcoma vaccine and its preparation method |
| 06/02/2009 | US7541443 A humanized antibody for use as immunosuppressants, treating or preventing transplant rejection in human patient; drug screening |
| 06/02/2009 | US7541440 Invention provides monoclonal antibody or fragment thereof that binds granulocyte (neutrophil) antigen, preferably provides humanized, chimeric and human anti-granulocyte-targeting antibodies, such as MN3 antibodies, useful for treatment and diagnosis of malignancy diseases resulting from ischemic injury |
| 06/02/2009 | US7541439 Thrombopoietin proteins with improved properties |
| 06/02/2009 | US7541437 Breast cancer resistance protein (BCRP) and the DNA which encode it |
| 06/02/2009 | US7541435 Antagonists of cxcr3-binding cxc chemokines |
| 06/02/2009 | US7541429 Comparative ligand mapping from MHC positive cells |
| 06/02/2009 | US7541334 Hybrid peptides modulate the immune response |
| 06/02/2009 | US7541330 Conjugates with reduced adverse systemic effects |
| 06/02/2009 | US7541328 Coupling proteins to a modified polysaccharide |
| 06/02/2009 | US7541180 comprising administering to a cells or tissues in vitro; hepatitis C virus (HCV) antigens; dna immunization |
| 06/02/2009 | US7541164 Mammalian cell culture processes for protein production |
| 06/02/2009 | US7541154 GASP1: a follistatin domain containing protein |
| 06/02/2009 | US7541044 stimulating antitumor immune responses; tissue-targeted therapy; first tumour antigen is used to treat secondary tumor; biodrug for cancer immunotherapy with cyclophosphamide |
| 06/02/2009 | US7541043 antigen is expressed from Salmonella enterica serovar Typhi strain Ty21a; gene cluster operably linked to transcriptional promoter and termination signals; for protecting the host against bacillary dysentery and shigellosis; immunotherapy |
| 06/02/2009 | US7541042 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 06/02/2009 | US7541041 Vaccine against dental caries based on virulence-associated immunomodulatory extracellular proteins produced by the cariogenic bacteria Streptococcus sobrinus and Streptococcus mutans |
| 06/02/2009 | US7541039 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 06/02/2009 | US7541038 Fusogenic, self-propagating blebs as immunogenic compositions |
| 06/02/2009 | US7541036 Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein |
| 06/02/2009 | US7541035 Immunogenic peptides for the treatment of prostate and breast cancer |
| 06/02/2009 | US7541034 Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors |
| 06/02/2009 | US7541033 Humanized anti-IL-1β antibodies |
| 06/02/2009 | US7541032 Antigen uptake receptor for Candida albicans on dendritic cells |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | US7541030 Antibodies for identifying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, mesenchymal stem cells and mesenchymal precursor cells |
| 06/02/2009 | US7541029 Anti-rhesus D monoclonal antibodies |
| 06/02/2009 | US7541027 polyclonal antibodies, monoclonal antibodies, F(ab')2, Fab and single chain Fv; tyrosine at position 1214 in the amino acid sequence of the vascular endothelial growth factor receptor |
| 06/02/2009 | CA2339089C Cold-adapted equine influenza viruses |
| 06/02/2009 | CA2321664C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/02/2009 | CA2274495C Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 06/02/2009 | CA2249351C Novel method of diagnosing and treating gliomas |
| 06/02/2009 | CA2190867C Methods for reduced renal uptake of antibody fragments |
| 06/02/2009 | CA2158475C Composition and method for reducing toxicity of biologically-active factors |
| 06/02/2009 | CA2068863C Particle-mediated transformation of animal tissue cells |
| 05/30/2009 | CA2618374A1 Trimeric collagen scaffold antibodies |
| 05/28/2009 | WO2009067349A2 Modulation of the immune response |
| 05/28/2009 | WO2009067020A1 Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites |
| 05/28/2009 | WO2009066824A1 Vaccine comprising monocyte or immature myeloid cells(imc) which were loaded with the ligand of natural killer t cell and antigen |
| 05/28/2009 | WO2009066763A1 Preparation for application to body surface and preparation holding sheet for application to body surface |
| 05/28/2009 | WO2009066702A1 Anti-hiv monoclonal antibody |
| 05/28/2009 | WO2009066655A1 Human antibody capable of inducing apoptosis |
| 05/28/2009 | WO2009066241A1 Antibody fragments inhibiting hiv nef protein |
| 05/28/2009 | WO2009066175A1 Peptide analogues and conjugates thereof |
| 05/28/2009 | WO2009066131A1 Methods for preparation of vaccines, laboratory kits, and treatment components |
| 05/28/2009 | WO2009065993A1 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-gmp synthesis obtained by said method |
| 05/28/2009 | WO2009065982A1 Peptides that can bind to scurfin and uses thereof |
| 05/28/2009 | WO2009065930A1 Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same |
| 05/28/2009 | WO2009065800A1 Recombinant human adenoviruses for eliciting mucosal immune responses |
| 05/28/2009 | WO2009065561A2 System for delivery into a xcr1 positive cell and uses thereof |
| 05/28/2009 | WO2009065546A1 Poxviral oncolytic vectors |
| 05/28/2009 | WO2009046405A3 Antibodies to htra1 and methods of using the same |
| 05/28/2009 | WO2009043191A3 Method for producing macro-porous materials |
| 05/28/2009 | WO2009043155A3 Distinct hiv-1 gag and env epitopes of hla alleles associated with differential susceptibility to hiv-1 infection |
| 05/28/2009 | WO2009040819A3 DOWN-REGULATION OF MORTALIN BY siRNA |
| 05/28/2009 | WO2009032845A3 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 05/28/2009 | WO2009032782A3 Compositions that bind multiple epitopes of igf-1r |
| 05/28/2009 | WO2009031151A3 Antibodies and methods for diagnosing and treating cancer |
| 05/28/2009 | WO2009027105A3 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders |
| 05/28/2009 | WO2009025770A3 A heterologous prime-boost immunization regimen |